|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.640 USD | -2.33% |
|
-2.43% | +70.62% |
| 07-13 | Stifel Nicolaus Initiates Coverage on Candel Therapeutics With Buy Rating, $22 Price Target | MT |
| 06-30 | Candel Therapeutics Stock Gains on Launch of Phase 3 Trial for Lung-Cancer Drug | DJ |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 10.36 | 10.36 | 9.83 |
| Spread/Res. | -6.95% | -6.95% | -1.93% |
| Spread/Supp. | +3.99% | +31.34% | +44.64% |
| Support | 9.27 | 7.34 | 6.665 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CADL Stock
- Charts Candel Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
